Skip to main content
Contact Us
Subscribe
E-Edition
78°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
IQVIA Holdings, Inc. Common Stock
(NY:
IQV
)
164.24
-0.41 (-0.25%)
Official Closing Price
Updated: 5:00 PM EDT, Jul 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about IQVIA Holdings, Inc. Common Stock
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
Global Oncology R&D Activity Remains High and More Patients Have Been Treated for Cancer, says IQVIA Institute for Human Data Science
May 24, 2023
From
IQVIA
Via
Business Wire
IQVIA Announces Pricing of Upsized Offering of Senior Secured Notes and Senior Notes
May 18, 2023
From
IQVIA Holdings Inc.
Via
Business Wire
IQVIA Announces Offering of Senior Secured Notes and Senior Notes
May 18, 2023
From
IQVIA
Via
Business Wire
IQVIA Hldgs's Return On Capital Employed Overview
May 02, 2023
Via
Benzinga
Expert Ratings for IQVIA Hldgs
April 28, 2023
Via
Benzinga
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,100 Today
April 19, 2023
Via
Benzinga
This Foreboding Sign Looms Over IQVIA Hldgs's Chart
April 07, 2023
Via
Benzinga
IQVIA Celebrates Sheetal Telang, Winner of Healthcare Businesswoman's Association Rising Star Award
May 11, 2023
From
IQVIA
Via
Business Wire
Use of Medicines in the U.S. Continued to Grow in 2022 while Patient Out-of-Pocket Costs Remain Low, Says IQVIA Institute
May 02, 2023
From
IQVIA
Via
Business Wire
IQVIA Reports First-Quarter 2023 Results; Reaffirms Full-Year 2023 Guidance
April 27, 2023
From
IQVIA Holdings Inc.
Via
Business Wire
Death Cross Looms Over IQVIA Hldgs Investors
April 06, 2023
Via
Benzinga
The Latest Analyst Ratings for IQVIA Hldgs
April 04, 2023
Via
Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today
April 04, 2023
Via
Benzinga
Here's How Much You Would Have Made Owning IQVIA Hldgs Stock In The Last 5 Years
March 29, 2023
Via
Benzinga
(IQV) - Analyzing IQVIA Hldgs's Short Interest
March 17, 2023
Via
Benzinga
IQVIA Named a Leader in Everest Group Life Sciences Customer Experience Platforms PEAK Matrix® Assessment 2023
April 20, 2023
From
IQVIA
Via
Business Wire
IQVIA to Announce First-Quarter 2023 Results on April 27, 2023
April 06, 2023
From
IQVIA Holdings Inc.
Via
Business Wire
2 Clinical Research Stocks That Could Grow by More Than 10% This Year, and 1 to Watch
March 25, 2023
These companies strive to bring down the cost of developing new therapies.
Via
The Motley Fool
What 6 Analyst Ratings Have To Say About IQVIA Hldgs
March 17, 2023
Via
Benzinga
Here's How Much $100 Invested In IQVIA Hldgs 5 Years Ago Would Be Worth Today
March 06, 2023
Via
Benzinga
Where IQVIA Hldgs Stands With Analysts
February 13, 2023
Via
Benzinga
IQVIA Clocks 2.8% Sales Growth In Q4, Beats Street View By A Whisker
February 10, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023
March 17, 2023
Via
Benzinga
Global Clinical Trial Activity Remained Resilient in 2022 Despite The Continued Pandemic, Says IQVIA Institute
March 14, 2023
From
IQVIA
Via
Business Wire
IQVIA CFO Ron Bruehlman to Speak at Barclays Global Healthcare Conference on March 15, 2023
March 01, 2023
From
IQVIA
Via
Business Wire
MannKind To Rally Around 30%? Here Are 10 Other Analyst Forecasts For Monday
February 27, 2023
Piper Sandler cut the price target for CS Disco, Inc. (NYSE: LAW) from $11 to $7.5. Piper Sandler analyst Arvind Ramnani downgraded the stock from Overweight to Neutral. CS Disco shares fell 1.2% to...
Via
Benzinga
IQVIA Publishes its 2022 Environmental, Social and Governance Report
February 23, 2023
From
IQVIA
Via
Business Wire
Got $300? 3 Growth Stocks to Buy That Could Double Your Money
February 21, 2023
All three companies have shown consistent revenue and EPS growth.
Via
The Motley Fool
7 Hot Healthcare Stocks With the Potential to Outperform
February 15, 2023
These healthcare stocks to buy now have the potential to outperform the market over the long-term because their businesses are strong.
Via
InvestorPlace
IQVIA Reports Fourth-Quarter and Full-Year 2022 Results; Issues Full-Year 2023 Guidance
February 10, 2023
From
IQVIA Holdings Inc.
Via
Business Wire
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.